On 23 July, Donald Trump signed three executive orders calling for the accelerated expansion of the U.S.’s artificial intelligence (AI) industry and announced an “AI Action Plan.”
Tag: U.S. Economy
TOP TREND 2023: OFFICE BUILDING BUST
An expected recovery in Europe’s commercial real estate market has failed to materialize, leaving property prices close to their lowest in almost a decade, Reuters reported.
U.S. ECONOMIC BRIEFS
U.S. retail sales rose 0.6 percent in June from May, while inflation ticked up only 0.3 percent over the same period.
SPOTLIGHT: THE U.S. HOUSING MARKET SLUMP
During the first week of July, mortgage applications to purchase a home or refinance a loan were 10 percent fewer than in the week before as the interest rate on a 30-year, fixed-rate loan rose from 6.77 percent to 6.82 percent, the Mortgage Bankers Association (MBA) reported.
MOST FORTUNE 100’S NOW MANDATE FULL-TIME OFFICE ATTENDANCE
For the first time since the COVID War began, more than half of Fortune 100 companies have brought their workers back to central offices full-time, according to a study by real estate firm Jones Lang LaSalle (JLL).
GOING OUT OF BUSINESS TRENDS
The economic landscape has presented an array of challenges that will profoundly affect the business community this year.
WHEN THE ECONOMY FALLS, JOBS GO WITH IT
The U.S. Department of Labor announced this month that “native-born workers” have accounted for all job gains since January amid historic immigration crackdowns.
ECONOMIC UPDATE—MARKET OVERVIEW
On the tariff side of life, today, the word is that Donald Trump’s tariff deadline with China will be extended, according to the U.S. Treasury Secretary mouthpiece Scott Bessent.
INVESTORS FLOOD MONEY INTO U.S. TECH STOCKS
Investors are snapping up U.S. tech stocks at the fastest pace since March 2009, according to a Bank of America survey.
SPOTLIGHT: BIGS GETTING BIGGER
Merck, the New Jersey drug giant, is paying $107 a share, or about $10 billion, to acquire Verona Pharma, a London company that makes a respiratory treatment that could bring $4 billion in annual sales in the next decade.









